Adult Vaccines Policy Research

Challenge

Some countries have included vaccines for adults in their national programs or have made recommendations for use of influenza, pneumococcal and herpes zoster vaccines, among others, but adoption and uptake has been slow, particularly in low and middle-income countries.  Although there has been a recent emphasis on a life-course approach to immunization, vaccines for older adults have not been prominent on the global agenda and factors influencing adoption, uptake, and the potential impact of coverage expansion have not been well-studied. 

Approach

IVAC is conducting policy research to contribute to: (1) establishing a summary resource of key data describing the state of adult vaccine policies and uptake around the world; (2) highlighting key factors that influence and guide the introduction and use of adult vaccines; and 3) developing a framework to assess country archetypes for adult immunization that could help inform data needs or approaches that support policy making, access and uptake.  

Additionally, IVAC is convening a diverse group of experts to examine the evidence and policy gaps in order to establish a road map for technical consensus and policy change.  The group, as part of the International Council on Adult Immunization (ICAI), will engage stakeholders around the world to build awareness about the value of adult immunization and advocate for evidence-based decisions and improved uptake of vaccines for older adults. 

Expected Results
  • Establishing a summary resource of key data describing the state of adult vaccine policies and uptake around the world 
  • Highlighting key factors that influence and guide the introduction and use of adult vaccines 
  • Developing a framework to assess country archetypes for adult immunization that could help inform data needs or approaches that support policy making, access, and uptake. 
  • Establishing a respected group of experts to help improve awareness around the value of immunization in older adults and help bring about evidence-based decisions and improved uptake for immunization in older adults.